Befotertinib

CAS No. 1835667-63-4

Befotertinib ( D-0316 )

Catalog No. M28217 CAS No. 1835667-63-4

Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 Get Quote
10MG 357 Get Quote
25MG 597 Get Quote
50MG 851 Get Quote
100MG 1152 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Befotertinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.
  • Description
    Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.
  • Synonyms
    D-0316
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    CDK2;CDK5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1835667-63-4
  • Formula Weight
    567.6
  • Molecular Formula
    C29H32F3N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C=CC(=O)NC1=CC(NC2=NC=CC(C3=CN(CC(F)(F)F)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(C)CCN(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ka?mierczak A, et al. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5). Neurochem Int. 2011;58(2):206-214.
molnova catalog
related products
  • Benidipine hydrochlo...

    Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

  • Pyrotinib

    Pyrotinib (SHR-1258)is a potent and selective EGFR/HER2 dual inhibitor with IC50 of 13/38 nM, respectively.

  • Erlotinib

    A potent, selective inhibitor of EGFR with IC50 of 2 nM; reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM.